It's time all clinical trial results are reported.
Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. Wherever you are in the world please sign the petition:
- Thousands of clinical trials have not reported their results; some have not even been registered.
- Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated.
- All trials past and present should be registered, and the full methods and the results reported.
- We call on governments, regulators and research bodies to implement measures to achieve this.
The petition has also been translated into many different languages. If you would like to sign the petition on behalf of an organisation then please contact us. Data will be held by Sense About Science. Read our privacy policy here.
Medtronic and Yale open data project
Medtronic and Yale open data project 19th June 2013 US company Medtronic has just heard the results from its groundbreaking project on clinical trial transparency. Two years ago Medtronic gave all the clinical trial data it has for one of its back surgery products to researchers at Yale University. The Yale experts commissioned two groups...
The AllTrials campaign petition
It’s time all clinical trial results are reported. Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. Wherever you are in the world please sign the petition: Thousands of clinical trials have not reported their results; some have not even been registered. Information on what was done and what...
AllTrials on the BBC Daily Politics today
19th June 2013 Drug firms should publish all of their scientific trials, and not just those they want to put in the public domain, says Dr Ben Goldacre in this short video about the AllTrials campaign. Dr Ben Goldacre will debate his film in the Daily Politics studio with the Labour’s Emily Thornberry and Conservative...
Drug companies have a year to publish their data, or we’ll do it for them
17th June 2013 By Tom Jefferson, Cochrane Collaboration As a doctor it’s my job to prescribe lotions and potions. To do so, I read information about drug trials in books and medical journals to keep me up to speed on the latest drugs, dangers and side effects. But what if what I read is part...
Negative results in medical research and clinical trials
11th June 2013 A brief interview with Dr Ben Goldacre explaining how medical research and patient treatment are affected by the lack of publication of negative data. You can read the full interview on the F1000Research blog.
RIAT initiative for publication of historical clinical trial findings
14th June 2013 The RIAT (restoring invisible and abandoned trials) initiative is launched by BMJ, PLOS and researchers today. It is a call to action to companies and academic funders to publish, or update already published, findings from trials they sponsored. The initiators of RIAT say they will make public all the confidential information they...
Drug safety relies on people like David tackling the Goliaths of big pharma
10th June 2013 By Edwin Gale, University of Bristol In 2001 I met David Graham, an official from the US Food and Drug Administration, in a car park in Washington. I wanted him to shed light on why the diabetes drug troglitazone, or Rezulin, had been available in the US and Japan two years after...
BMJ Open Data Campaign
6th June 2013 Medical student Alice Buchan talks about the BMJ Open Data Campaign and why doctors cannot make evidence-based decisions without all the data. You can read the full blog on the Students 4 Best Evidence blog here.
Patient perspective
5th June 2013 Motor Neurone Disease patient Les Halpin speaks with pharmaphorum’s Rebecca Aris about why he believes that publicly sharing all clinical trial data is critical and his campaign to raise the issue of earlier access to medicine higher up both the political and media agenda. You can read the full Patient Perspective interview on...
Ministers answer questions on clinical trials
4th June 2013 Here’s a link to yesterday’s very interesting session on clinical trials in the House of Commons Science and Technology committee with David Willetts MP, Minister at the Department for Business, Innovation and Skills and Lord Howe, Minister for Health. It was great to hear Lord Howe say the UK Government was “squarely...
Government ministers to be quizzed on clinical trials
3rd June 2013 David Willetts MP, Minister at the Department for Business, Innovation and Skills and Lord Howe, Minister for Health, will appear before the House of Commons Science and Technology committee’s inquiry into clinical trials at 4.30pm today. You can watch the session on Parliament TV. There are a couple of important questions that...
Tamiflu cost us £424m yet we still don’t know much about it
3rd June 2013 By Tom Jefferson, Cochrane Collaboration Are you worried about how decisions involving public money are made? You should be. Last week, the National Audit Office disclosed that the Department of Health spent £424 million on the anti-flu drug Tamiflu. The money was used to purchase nearly 40 million units of the medicine...
AllTrials is an initiative of Sense About Science, Bad Science, BMJ, James Lind Initiative, the Centre for Evidence-based Medicine, PLOS, the Cochrane Collaboration and in the US Dartmouth’s Geisel School of Medicine and the Dartmouth Institute for Health Policy & Clinical Practice.
